<DOC>
	<DOC>NCT01422538</DOC>
	<brief_summary>This clinical trial will evaluate clinical outcomes associated with the non-invasive Ultherapy™ treatment to improve skin laxity and tightening following a Sculptra® treatment.</brief_summary>
	<brief_title>Ultherapy™ Treatment Following Sculptra® Treatment</brief_title>
	<detailed_description>This study is a prospective,single-center, randomized clinical trial. Up to thirty (30) subjects will be treated. Enrolled subjects will be assigned to one of three (3) groups. Up to 10 subjects per group.</detailed_description>
	<mesh_term>Cutis Laxa</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<criteria>Male or female, aged 35 to 60 years. Subject in good health. Skin laxity in the lower face and neck. Grade 1 and 2 on the Knize Scale Presence of an active systemic or local skin disease that may affect wound healing. Severe solar elastosis. Excessive subcutaneous fat in the face and neck. Excessive skin laxity on the face and neck. No scarring in areas to be treated. Any open facial wounds or lesions. Acne on the face. Patients who have a history with keloid formation or hypertropic scarring Patients who have a hypersensitivity to injectable polyLlactic acid Presence of a metal stent or implant in the facial area to be treated.</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Ulthera® System</keyword>
	<keyword>Ultherapy™ treatment</keyword>
	<keyword>Ulthera, Inc.</keyword>
	<keyword>Ultrasound treatment for skin tightening</keyword>
	<keyword>Skin laxity on the face and neck.</keyword>
</DOC>